OR WAIT null SECS
© 2021 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
RIVERDALE ANESTHESIA ASSOCIATES PC
405 ARROWHEAD BLVD
Keith Loria is a contributing writer to Medical Economics.
October 07, 2021
Many states only have vaguely worded qualitative standards for network adequacy for cancer care. Others have quantitative standards based on distance or waiting time.
September 16, 2021
States are putting caps on prices, and Semglee, the first interchangeable biosimilar in the United States, may exert some downward pressure.
September 15, 2021
CVS’ Joshua Fredell, Pharm.D., and Tierra Ford, Pharm.D., described how an integrated, proactive approach can engage members and rein in costs.
September 14, 2021
Treatments aimed at certain mutations have proliferated and moved upstream to earlier-stage lung cancers. But there are many questions about insurance coverage and which tests to use to identify the biomarkers that help guide treatment.